We are live on ! Find out more
PCA

Private Capital Advisors Portfolio holdings

AUM $1.14B
1-Year Est. Return 48.66%
This Fund
S&P 500
This Quarter Est. Return
+11.1%
1 Year Est. Return
+48.66%
3 Year Est. Return
+137.63%
5 Year Est. Return
+227.94%
10 Year Est. Return
+772.14%
AUM
$292M
AUM Growth
+$16.8M
Cap. Flow
-$7.89M
Cap. Flow %
-2.7%
Top 10 Hldgs %
29.91%
Holding
120
New
8
Increased
27
Reduced
29
Closed
13

Top Buys

Rank Stock Value
1
SGMO
SANGAMO THERAPEUTICS INC
SGMO
+$12.2M
2
ARWR icon
Arrowhead Research
ARWR
+$3.01M
3
BIIB icon
Biogen
BIIB
+$2.76M
4
GILD icon
Gilead Sciences
GILD
+$1.62M
5
BIDU icon
Baidu
BIDU
+$1.52M

Sector Composition

Rank Sector Weight
1 Healthcare 22.95%
2 Energy 16.91%
3 Communication Services 13.82%
4 Industrials 9.86%
5 Consumer Discretionary 8.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MOS icon
51
The Mosaic Company
MOS
$7.5B
$1.94M 0.66%
41,054
-550
-1% -$25.5K
DT
52
DELISTED
DEUTSCHE TELEKOM AG ADS (1ORD)
DT
$1.92M 0.66%
111,205
-500
-0.4% -$8.63K
DVY icon
53
iShares Select Dividend ETF
DVY
$23.8B
$1.87M 0.64%
26,175
BIDU icon
54
Baidu
BIDU
$32.9B
$1.67M 0.57%
+9,400
New +$1.52M
MDXG icon
55
MiMedx Group
MDXG
$656M
$1.65M 0.56%
188,436
-50,000
-21% -$306K
ABT icon
56
Abbott
ABT
$195B
$1.57M 0.54%
41,100
-100
-0.2% -$3.69K
CMG icon
57
Chipotle Mexican Grill
CMG
$48.1B
$1.54M 0.53%
+145,000
New +$1.47M
ARIA
58
DELISTED
Ariad Pharmaceuticals Inc
ARIA
$1.43M 0.49%
+210,000
New +$1.13M
UAN icon
59
CVR Partners
UAN
$1.32B
$1.34M 0.46%
8,156
IRWD icon
60
Ironwood Pharmaceuticals
IRWD
$682M
$1.3M 0.45%
133,728
-143,877
-52% -$1.29M
OMC icon
61
Omnicom Group
OMC
$24.2B
$1.19M 0.41%
16,000
MWV
62
DELISTED
MEADWESTVACO CORP
MWV
$1.18M 0.4%
31,909
PER
63
DELISTED
SANDRIDGE PERMIAN TRUST
PER
$1.15M 0.39%
97,100
-250
-0.3% -$3.39K
JNJ icon
64
Johnson & Johnson
JNJ
$646B
$1.03M 0.35%
11,208
+22
+0.2% +$2.03K
SPY icon
65
State Street SPDR S&P 500 ETF Trust
SPY
$825B
$849K 0.29%
+4,595
New +$813K
PSX icon
66
Phillips 66
PSX
$97.4B
$787K 0.27%
10,200
-15,300
-60% -$1.02M
OXY icon
67
Occidental Petroleum
OXY
$59.1B
$747K 0.26%
8,194
CHTR icon
68
Charter Communications
CHTR
$18.3B
$711K 0.24%
5,200
CVS icon
69
CVS Health
CVS
$119B
$605K 0.21%
8,450
QQQ icon
70
Invesco QQQ Trust
QQQ
$489B
$591K 0.2%
6,720
DISH
71
DELISTED
DISH Network Corp.
DISH
$591K 0.2%
10,200
ORCL icon
72
Oracle
ORCL
$435B
$557K 0.19%
14,555
MSFT icon
73
Microsoft
MSFT
$3.81T
$556K 0.19%
14,875
GE icon
74
GE Aerospace
GE
$355B
$555K 0.19%
4,132
BALL icon
75
Ball Corp
BALL
$16.9B
$520K 0.18%
20,120

Similar funds

Private Capital Advisors's Q4 2013 Portfolio in Review

As of Q4 2013, Private Capital Advisors held 120 positions worth $292M, up 6.1% from $275M the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Private Capital Advisors's Q4 2013 filing shows 8 new, 27 increased, 29 reduced and 13 closed positions. Its largest new stake was SANGAMO THERAPEUTICS INC: 1,059,000 shares worth $14.7M. The largest sale was BioMarin Pharmaceuticals, an estimated $6.53M.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, up from 20% a quarter earlier, followed by Energy and Communication Services.

  • Private Capital Advisors's largest Q4 2013 buy was SANGAMO THERAPEUTICS INC: 1,059,000 shares worth $14.7M.
  • Private Capital Advisors added most to Biogen in Q4 2013, an estimated $2.76M increase.
  • Private Capital Advisors's biggest Q4 2013 reduction was Alphabet (Google) Class C, cutting an estimated $4.85M.
  • Private Capital Advisors fully exited BioMarin Pharmaceuticals in Q4 2013, selling an estimated $6.53M.
  • Private Capital Advisors's ten largest holdings make up 30% of its $292M portfolio in Q4 2013.
  • Private Capital Advisors opened 8 new positions and closed 13 in Q4 2013.
  • Private Capital Advisors's portfolio value rose 6.1% quarter-over-quarter to $292M.

Based on Private Capital Advisors's 13F filing for Q4 2013, filed 31 Jan 2014.